Search Results - "van Vliet, I"

Elevated alpha-amylase but not cortisol in generalized social anxiety disorder by van Veen, J.F, van Vliet, I.M, DeRijk, R.H, van Pelt, J, Mertens, B, Zitman, F.G

“…Summary Stress-system dysregulation is thought to increase the risk for anxiety disorders. Here we describe both hypothalamic pituitary adrenal (HPA) axis and…”
Get full text

Cost-effectiveness analysis of the treatment of posttraumatic stress disorder related to childhood abuse: comparison of phase-based treatment and direct trauma-focused treatment by van Vliet, Noortje I, Stant, A Dennis, Huntjens, Rafaele, van Dijk, Maarten K, de Jongh, Ad

“…Policymakers, health insurers, and health care providers are becoming increasingly interested in cost-effectiveness analyses (CEA's) when choosing between…”
Get full text

Phase-based treatment versus immediate trauma-focused treatment for post-traumatic stress disorder due to childhood abuse: randomised clinical trial by van Vliet, Noortje I., Huntjens, Rafaele J. C., van Dijk, Maarten K., Bachrach, Nathan, Meewisse, Marie-Louise, de Jongh, Ad

“…Background It is unclear whether people with post-traumatic stress disorder (PTSD) and symptoms of complex PTSD due to childhood abuse need a treatment…”
Get full text

Predictors and moderators of treatment outcomes in phase-based treatment and trauma-focused treatments in patients with childhood abuse-related post-traumatic stress disorder by van Vliet, Noortje I, Huntjens, Rafaele J C, van Dijk, Maarten K, Huisman, Mark, Bachrach, Nathan, Meewisse, Marie-Louise, van Haren, Sietske, de Jongh, Ad

“…Knowledge of treatment predictors and moderators is important for improving the effectiveness of treatment for PTSD due to childhood abuse. The first aim of…”
Get full text

An Evaluation of Irreversible Psychosurgical Treatment of Patients With Obsessive-Compulsive Disorder in the Netherlands, 2001–2008 by van Vliet, I.M, van Well, E.P.L, Bruggeman, Richard, Campo, Joost á, Hijman, R, van Megen, H.J.G.M, van Balkom, A.J.L.M, van Rijen, P.C

“…ABSTRACTAdmissions for irreversible psychosurgical treatment of obsessive-compulsive disorder (OCD) by the Working Group for Indication Psychosurgery in the…”
Get full text

Improved Control of Severe Hypoglycemia in Patients with Malignant Insulinomas by Peptide Receptor Radionuclide Therapy by van Schaik, E, van Vliet, E. I, Feelders, R. A, Krenning, E. P, Khan, S, Kamp, K, Valkema, R, van Nederveen, F. H, Teunissen, J. J. M, Kwekkeboom, D. J, de Herder, W. W

“…Context: Insulinomas are relatively rare neuroendocrine tumors of the pancreas. Only 10% are considered malignant. Control of insulin hypersecretion and…”
Get full text

Peptide receptor radionuclide therapy (PRRT) for GEP-NETs by Bergsma, Hendrik, MD, PhD, van Vliet, Esther I., MD, PhD, Teunissen, Jaap J.M., MD, PhD, Kam, Boen L.R., MD, de Herder, Wouter W., MD, PhD, Peeters, Robin P., MD, PhD, Krenning, Eric P., MD, PhD, Kwekkeboom, Dik J., MD, PhD

“…Abstract Peptide receptor radionuclide therapy (PRRT) with radiolabelled somatostatin analogues plays an increasing role in the treatment of patients with…”
Get full text

Distribution of fibronectin isoforms in human renal disease by Van Vliet, Anita I., Baelde, Hans J., Vleming, Louis-Jean, de Heer, Emile, Anthonie Bruijn, Jan

“…Fibronectin (FN) is an extracellular matrix component which appears in different isoforms, due to alternative mRNA splicing of the ED‐A, ED‐B, and IIICS…”
Get full text

The effects of paroxetine on the pharmacokinetics of paliperidone extended-release tablets by Berwaerts, J, Cleton, A, Herben, V, van de Vliet, I, Chang, I, van Hoek, P, Eerdekens, M

“…Co-morbid medical and psychiatric conditions are common in individuals with schizophrenia. As such, selecting antipsychotic medications with a low potential…”
Get more information

Psychopharmacological treatment of social phobia : a double blind placebo controlled study with fluvoxamine by VAN VLIET, I. M, DEN BOER, J. A, WESTENBERG, H. G. M

“…Previous studies have shown selective and nonselective monoamine oxidase inhibitors (MAOIs) to be effective in the treatment of social phobia. In this study we…”
Get full text

Clinical and sociodemographic associations with treatment selection in major depression by Rodenburg-Vandenbussche, S., Carlier, I.V.E., van Vliet, I.M., van Hemert, A.M., Stiggelbout, A.M., Zitman, F.G.

“…To investigate treatment selection in a naturalistic sample of MDD outpatients and the factors influencing treatment selection in specialized psychiatric care…”
Get full text

Mirtazapine in social anxiety disorder: a pilot study by Van Veen, J.F, Van Vliet, I.M, Westenberg, H.G.M

“…Fourteen patients with social anxiety disorder (generalized type), according to DSM-IV criteria, were treated with mirtazapine 30 mg for 12 weeks. Twelve…”
Get full text

Increased risk of major bleeding after a minor bleed during treatment with vitamin K antagonists is determined by fixed common risk factors by Rein, N., Cessie, S., Vliet, I. P., Reitsma, P. H., Meer, F. J. M., Lijfering, W. M., Cannegieter, S. C.

“…Essentials Minor bleeding is associated with subsequent major bleeding in patients treated with vitamin K antagonists. This study confirms that patients with…”
Get full text

Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study by Heijdra, Jessica M, Al Arashi, Wala, de Jager, Nico C B, Cloesmeijer, Michael E, Bukkems, Laura H, Zwaan, Christian M, Leebeek, Frank W G, Mathôt, Ron A A, Cnossen, Marjon H, Cnossen, MH, Leebeek, FWG, Fijnvandraat, K, Mathôt, RAA, Meijer, K, Kruip, MJHA, Polinder, S, Coppens, M, Tamminga, RYJ, Laros-van Gorkom, BAP, Brons, P, Schols, SEM, van der Meer, FJM, Eikenboom, HCJ, Schutgens, REG, Fischer, K, Heubel-Moenen, F, Nieuwenhuizen, L, Ypma, P, Driessens, MHE, Zwaan, CM, van Vliet, I, Collins, PW, Liesner, R, Chowdary, P, Keeling, D, Lock, J, Hazendonk, HCAM, van Moort, I, Preijers, T, Heijdra, JM, de Jager, NCB, Goedhart, MCHJ, Bukkems, LH, Al Arashi, W, Cloesmeijer, ME, Janssen, A

“…IntroductionVon Willebrand disease (VWD) is a bleeding disorder, caused by a deficiency or defect of von Willebrand factor (VWF). In case of medical procedures…”
Get full text

Characteristics of patients with social phobia and their treatment in specialized clinics for anxiety disorders in the Netherlands by Dingemans, A.E, van Vliet, I.M, Couvée, J, Westenberg, H.G

“…Background: Social phobia frequently occurs in the general population but is probably underreported due to comorbid disorders which mask the social phobia…”
Get full text

Fibronectin accumulation in glomerulosclerotic lesions: Self-assembly sites and the heparin II binding domain by Van Vliet, Anita I., Van Alderwegen, Isolde E., Baelde, Hans J., De Heer, Emile, Bruijn, Jan A.

“…Fibronectin accumulation in glomerulosclerotic lesions: Self-assembly sites and the heparin II binding domain. Glomerulosclerosis is a severe complication of…”
Get full text

Predictors of treatment dropout in patients with posttraumatic stress disorder due to childhood abuse1 by Bremer-Hoeve, Susanne, van Vliet, Noortje I., van Bronswijk, Suzanne C., Huntjens, Rafaele J.C., de Jongh, Ad, van Dijk, Maarten K.

“…Background Knowledge about patient characteristics predicting treatment dropout for post-traumatic stress disorder (PTSD) is scarce, whereas more understanding…”
Get full text

The clinical effectiveness of concise cognitive behavioral therapy with or without pharmacotherapy for depressive and anxiety disorders; a pragmatic randomized controlled equivalence trial in clinical practice by Meuldijk, D, Carlier, I.V.E, van Vliet, I.M, van Veen, T, Wolterbeek, R, van Hemert, A.M, Zitman, F.G

“…Abstract Background Depressive and anxiety disorders contribute to a high disease burden. This paper investigates whether concise formats of cognitive…”
Get full text

Lutetium-labelled peptides for therapy of neuroendocrine tumours by Kam, B. L. R., Teunissen, J. J. M., Krenning, E. P., de Herder, W. W., Khan, S., van Vliet, E. I., Kwekkeboom, D. J.

“…Treatment with radiolabelled somatostatin analogues is a promising new tool in the management of patients with inoperable or metastasized neuroendocrine…”
Get full text

Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [177Lu-DOTA0,Tyr3]Octreotate by van Vliet, Esther I, van Eijck, Casper H, de Krijger, Ronald R, Nieveen van Dijkum, Elisabeth J, Teunissen, Jaap J, Kam, Boen L, de Herder, Wouter W, Feelders, Richard A, Bonsing, Bert A, Brabander, Tessa, Krenning, Eric P, Kwekkeboom, Dik J

“…Pancreatic neuroendocrine tumors (NETs) are rare neoplasms for which surgery has almost the only potential for cure. When surgery is not possible because of…”
Get full text